Illumina (ILMN) Other Non-Current Liabilities (2010 - 2026)
Illumina's (ILMN) quarterly Other Non-Current Liabilities came in at $289.0 million in Q2 2026, down 16.95% on a YoY basis from $348.0 million in Q2 2025, and down 17.9% quarter-over-quarter from $352.0 million in Q1 2026.
Analysis
Illumina (ILMN) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Illumina (ILMN) has reported Other Non-Current Liabilities for 17 consecutive years, with $289.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Liabilities fell 16.95% year-over-year to $289.0 million; the trailing twelve-month figure through Jun 2026 stood at $289.0 million (down 16.95% YoY), and the FY2025 full-year result was $360.0 million, up 6.19% from the prior year.
- Other Non-Current Liabilities eased to $289.0 million in Q2 2026 per ILMN's latest filing, from $352.0 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $915.0 million in Q1 2022 and bottomed at $289.0 million in Q2 2026.
- Historically, Other Non-Current Liabilities has averaged $529.4 million across 5 years, with a median of $555.0 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities jumped 269.0% in 2022, then tumbled 52.85% in 2024.
- Over 5 years, Other Non-Current Liabilities stood at $613.0 million in 2022, then climbed by 1.14% to $620.0 million in 2023, then plunged by 45.32% to $339.0 million in 2024, then gained by 6.19% to $360.0 million in 2025, then retreated by 19.72% to $289.0 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $289.0 million, $352.0 million, and $360.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 289.00 Mn |
| Mar 29, 2026 | 352.00 Mn |
| Dec 28, 2025 | 360.00 Mn |
| Sep 28, 2025 | 334.00 Mn |
| Jun 29, 2025 | 348.00 Mn |
| Mar 30, 2025 | 344.00 Mn |
| Dec 29, 2024 | 339.00 Mn |
| Sep 29, 2024 | 313.00 Mn |
| Jun 30, 2024 | 331.00 Mn |
| Mar 31, 2024 | 642.00 Mn |
| Dec 31, 2023 | 620.00 Mn |
| Oct 1, 2023 | 555.00 Mn |
| Jul 2, 2023 | 702.00 Mn |
| Apr 2, 2023 | 654.00 Mn |
| Jan 1, 2023 | 649.00 Mn |
| Oct 2, 2022 | 613.00 Mn |
| Jul 3, 2022 | 853.00 Mn |
| Apr 3, 2022 | 845.00 Mn |
| Jan 2, 2022 | 915.00 Mn |
| Oct 3, 2021 | 1.09 Bn |